Rab22A Activators refers to a collection of chemical compounds that, either directly or indirectly, are capable of stimulating the activity of the Rab22A protein, a member of the RAS oncogene family. These activators often interact with the complex network of cellular processes and signaling pathways in which Rab22A is involved. While they may not directly bind to and activate Rab22A, they can impact the cellular environment in a way that leads to its activation. This class of compounds is diverse and includes a broad range of molecules, each with unique properties and modes of action. Among the activators, some interact with the endocytic pathway, which Rab22A is known to be involved in.
Other activators can stimulate membrane trafficking events. Some activators exert their effect by disrupting or stabilizing cellular structures that are crucial for Rab22A's role in vesicular trafficking. In addition, many activators are inhibitors of key enzymes or proteins in signaling pathways that impact Rab22A's function. Inhibitors of PI3K, a key player in endocytosis and membrane trafficking pathways, and can indirectly activate Rab22A by stimulating these pathways. A phospholipase C (PLC) inhibitor, could catalyze Rab22A activity by promoting membrane trafficking, while disrupting the Golgi apparatus, potentially igniting Rab22A activity by promoting vesicular trafficking processes.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA can trigger Protein Kinase C (PKC), which could indirectly initiate RAB22A activity by stimulating membrane trafficking events. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin, a PI3K inhibitor, could indirectly provoke RAB22A activity by stimulating endocytosis and membrane trafficking pathways. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 could indirectly spark RAB22A activity by initiating endocytosis and membrane trafficking pathways. | ||||||
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $31.00 $53.00 $124.00 $374.00 | 25 | |
By disrupting the Golgi apparatus, Brefeldin A could indirectly ignite RAB22A activity by promoting vesicular trafficking processes. | ||||||
Monensin A | 17090-79-8 | sc-362032 sc-362032A | 5 mg 25 mg | $155.00 $525.00 | ||
Monensin, by disrupting endosomal trafficking, could indirectly spur RAB22A activity as it is involved in this process. | ||||||
Nocodazole | 31430-18-9 | sc-3518B sc-3518 sc-3518C sc-3518A | 5 mg 10 mg 25 mg 50 mg | $59.00 $85.00 $143.00 $247.00 | 38 | |
Nocodazole, by disrupting microtubules, could indirectly stimulate RAB22A activity by promoting vesicular transport processes. | ||||||
Taxol | 33069-62-4 | sc-201439D sc-201439 sc-201439A sc-201439E sc-201439B sc-201439C | 1 mg 5 mg 25 mg 100 mg 250 mg 1 g | $41.00 $74.00 $221.00 $247.00 $738.00 $1220.00 | 39 | |
Paclitaxel could indirectly provoke RAB22A activity by stabilizing microtubules, enhancing vesicular transport processes. | ||||||
Ciliobrevin D | 1370554-01-0 | sc-507482 | 10 mg | $413.00 | ||
Ciliobrevin D, a dynein inhibitor, could indirectly spark RAB22A activity by affecting transport along microtubules, a key process in endosomal trafficking. | ||||||
Cytochalasin D | 22144-77-0 | sc-201442 sc-201442A | 1 mg 5 mg | $165.00 $486.00 | 64 | |
Cytochalasin D could indirectly catalyze RAB22A activity by disrupting actin filaments and thereby promoting vesicle trafficking. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin, an mTOR inhibitor, could potentially indirectly activate RAB22A by promoting vesicle trafficking processes. | ||||||